Full Press Release Details
IMRALDI®, Biogen’s Adalimumab Biosimilar Referencing Humira®, is Approved in the European Union.
BIIB
IMRALDI®, Biogen’s Adalimumab Biosimilar Referencing Humira®, is Approved in the European Union
Key Takeaway: IMRALDI®, Biogen’s Adalimumab Biosimilar Referencing Humira®, is Approved in the European Union